Sylvain Baize
4Patents
0h-index
12Co-inventors
31Inventor score
Filing activity: Jan 27, 2016 → Nov 30, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10849969B2 | Recombinant attenuated Mopeia virus comprising a modified nucleoprotein with reduced exonuclease activity | Chemistry; Metallurgy | 0 | Active |
| US11976305B2 | Lassa vaccine | Chemistry; Metallurgy | 0 | Active |
| US11638751B2 | Immunogenic composition comprising a recombinant attenuated mopeia virus with a modified nucleoprotein displaying reduced exonuclease activity | Chemistry; Metallurgy | 0 | Active |
| US10098879B2 | Methods and pharmaceutical compositions for the treatment of ebola virus disease | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.